That's essential, due to the fact that the method a protein in the body folds identifies if a pharmaceutical will have the ability to bind to that protein and work. Simply put, we need to know how these proteins fold if we want a drug to work. Historically, this has been an experimental procedure (legacy report prediction). And now, Alpha, Fold can predict protein folding with 92. 4% precision. That's going to make it a lot easier to produce drugs that do what they're developed to do. This was a development practically nobody saw. But it's going to have extensive implications for treating disease. I anticipate that Alpha, Fold will be 98% accurate by the end of 2021.
And, of course, there will be lots of financial investment opportunities in this area, too. Moving topics It's going to be a good year for bitcoin. I'm bullish on it in 2021 (jeff brown 2020 predictions). That stated, I still think bitcoin will continue to be unstable. We're close to all-time highs. I would not be amazed if it drew back maybe considerably prior to going greater - jeff brown prediction for 2021. I have actually been covering bitcoin for a long time now. Among the very first research study reports I ever released was on bitcoin. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $34,000 today.
However at the time of that initial recommendation, I titled my report "What's the Big Offer With Bitcoin?" That reveals you where the conversation was at the time. We were mostly educating readers. But that's not the big concern anymore. Now we're seeing institutional cash finally take an interest in bitcoin. Massachusetts Mutual Life Insurance coverage took a $100 million stake in bitcoin in December. This is not some little, niche enterprise. Mass, Mutual is a trusted 170-year-old institution. So think of that. In five years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake.
Which's a huge reason I'm bullish on it this year. jeff brown top biotech 2020. Regards, Jeff Brown, Editor, The Bleeding Edge I have a perk forecast 2020 was a record year for IPOs. 552 U.S. business went public the most in more than 20 years. These companies raised an overall of $172 billion. That's an all-time high beating the previous yearly record by 43%. I anticipate 2021 will be another record year in IPOs. There are a lot of terrific personal business on the brink of striking the general public markets And I have actually been working on a brand-new way for you to invest even before these business go public.
This opportunity has actually been constructing over the last couple of years. I can't wait to tell you all about it. Join me tomorrow at 8 p. m. ET for my Pre-IPO Code Event to learn all the information. Go right here to reserve your area free of charge.
Emma Walsh here, managing editor of the Journal. Regular Diary readers understand that tech isn't our normal beat (diplomatic relations). And when it comes to tech investing, we leave it to the professionals. The good news is, we have numerous such experts in our Rolodex. Our colleague Jeff Brown will recognize to our long time readers. He is among the most accomplished tech investing experts we understand (exponential tech investor). In reality, he had numerous triple-digit returns in his Brownstone Research portfolios in 2015. Here's what Jeff thinks the tech sector will bring us in 2021 Each year, I like to take a look at the big image and predict what's just around the corner.
That includes things like 5G networks, biotech, synthetic intelligence, and a lot more. These trends are experiencing rapid growth and creating amazing chances for investors. I desire to make certain all our readers are prepared for what's next. And with that in mind, let me draw the picture of what I see can be found in the next 12 months Our brand-new 5G (fifth-generation) cordless networks are a subject I have actually been covering for years now. jeff brown stock predictions. But despite what lots of readers might think, this is a pattern that's just getting going. Even though the COVID-19 pandemic interrupted supply chains last year, an outstanding 250 million 5G-enabled devices were still sold.
And all of this eventually resulted in Apple postponing the release of the 5G-enabled i, Phone 12 by two months (artificial intelligence). Losing two months of production and sales truly affects how lots of 5G devices are offered in the fiscal year. When you think about all of that, selling 250 million units is amazing. More significantly, the delays triggered by the pandemic produced a load of bottled-up need. Which need is now going to be pushed into 2021. In truth, I anticipate that more than 500 million 5G gadgets will be shipped in 2021 - jeff bezos. And that's not my only 5G prediction When I've discussed 5G in the past, I've explained its 3 various stages.
In Stage 2, 5G gadgets go on sale. 5G phones and other items start to reach customers. And in Stage Three, 5G services start to be offered (biotech stocks). That's when we begin to see applications working on 5G networks. Think of things like enormous multiplayer games over a cellphone. That's not possible with 4G. It will be with 5G. And my second 5G forecast for 2021 is that we will start Stage 3 by this summer. This begins something of a virtuous cycle: The majority of people don't actually care about the innovation. But they will care if there are amazing applications that can just be accessed with a 5G phone.
That causes more 5G apps being established. In fact, 5G is going to open a suite of extraordinary applications: self-driving cars, the Web of Things, robotic surgery, and more. All of these innovations require 5G. The investment opportunities going forward will be massive. Stepping far from 5G, the next important technology I visualize in 2021 is CRISPR genetic editing. CRISPR represents "clustered routinely interspaced short palindromic repeat." It's a mouthful. But it's one of the most interesting developments in biotechnology. At a high level, CRISPR is an innovation that can edit our hereditary makeup as if it were software application.
The program can crash or not operate correctly. CRISPR uses a comparable concept however with our genetic code. "Typos" in our genome can lead to disease. CRISPR can correct these "typos." For several years, CRISPR was primarily a niche technology that wasn't well comprehended. And throughout that time, there were really only 3 business running in this area. But things are changing. CRISPR is no longer just theoretical. We're seeing real outcomes. We're dealing with diseases and seeing that this innovation just works. And as a result, a "2nd crop" of early-stage CRISPR companies is going public and delivering extraordinary returns. This entire industry is successfully a greenfield chance.
There's space for many companies to exist in this space. jeff brown 1 biotech company. And there will be more. That's my forecast for CRISPR in 2021. I anticipate that two or 3 more genetic editing companies will hold their IPOs. Sticking to biotechnology, we are seeing remarkable things happening at the merging of biotech and synthetic intelligence (AI). Google's AI subsidiary, Deep, Mind, simply revealed at the end of 2020 that its newest Alpha, Fold software can precisely predict the folding of a protein based entirely on its amino acid sequence with 92. 4% precision. That is essential due to the fact that the method a protein in the body folds figures out if a pharmaceutical will be able to bind to that protein and be reliable.
Historically, this has been a trial-and-error procedure. And now, Alpha, Fold can anticipate protein folding with 92. 4% precision. That's going to make it much simpler to create drugs that do what they're created to do. And here's my next forecast. I predict that Alpha, Fold will be 98% precise by the end of 2021. And we will see not simply one but several drug treatments produced using this technology. This was one of those developments that almost nobody discovered. But it's going to have extensive ramifications for treating disease. And, naturally, there will be lots of financial investment opportunities in this space, too.
It's going to be a great year for bitcoin. I'm bullish on it in 2021. That said, I still believe bitcoin will continue to be volatile. We're close to all-time highs. I would not be amazed if it drew back maybe significantly prior to going greater. I have actually been covering bitcoin for a very long time now. One of the very first research study reports I ever released was on bitcoin - tech stock. That was in June 2015. At the time, bitcoin was trading for about $240. Bitcoin trades for over $40,000 today. So that's a 16,500%+ roi for anybody who followed my recommendation. But at the time of that initial recommendation, I titled my report, "What's the Big Deal With Bitcoin?" That shows you where the discussion was at the time.
However nobody is asking that question anymore. Now, we're seeing institutional cash lastly taking an interest in bitcoin. The huge news was that Massachusetts Mutual Life Insurance took a $100 million stake in bitcoin in December. This is not some small, niche business. longtime readers. Mass, Mutual is a 150-year-old organization. So consider that. In 5 years, we went from informing readers on what bitcoin is to a company like Mass, Mutual taking a $100 million stake. The institutional adoption of bitcoin will continue. And that's a big reason why I'm bullish on it this year. Regards, Jeff Brown, Editor, The Bleeding Edge I have another perk forecast In 2021, we're going to have another record year in IPOs. One site reports that Jeff Brown is worth about $27. 5 million and claims the details depends on date as of February 2021, but we could not independently verify this claim. Offered Jeff Brown's past, he likely has a considerable net worth, but we can't hammer down an exact figure at this moment. Brown is best understood for his sage-like ability to select winning innovation stocks. He invested more than 25 years researching innovation companies like Qualcomm, NXP semiconductors, and Juniper Networks. Brown's comprehensive experience gives him an excellent viewpoint on the marketplace. He's constantly on the hunt for new opportunities, and he shares a number of his finest picks in the Future Report.
That's full marks, but it's not ridiculously reasoned. Brown has an outstanding reputation as a stock-picker, and he effectively anticipated some of the greatest financial occasions of the previous twenty years. Although he doesn't appear to release his choices to the public, the service's success is a direct indication of Brown's stock-picking prowess. No one on Wall Street gets it right every time, but Jeff Brown's accurate predictions have actually made him legions of dedicated followers. That states a lot about his capability. The Near Future Report is published by Brownstone Research, a popular financial research study publisher. Brownstone Research uses numerous research services with a wide array of specializations - jeff brown genetic sequencer stock.
The business is likewise associated with Bonner & Partners, another well-respected research study publisher - diplomatic relations. On its site, Brownstone says its objective is to provide retail investors with professional-grade research study: "For too long, the best financial investment research has not been readily available to individual financiers. It has actually been generally reserved for investment banks, hedge funds, private equity, and high-net-worth customers. second wave. The objective of Brownstone Research study is to make that type of proprietary research study available to any financiers looking to gain an edge in the markets. The objective is basic to provide special and successful investment research study found no place else." -Brownstone Research site excerpt from the Jeff Brown is the creator of Brownstone Research, and he also functions as the company's Chief Investment Expert.
With Brown guiding the ship, Brownstone Research is a powerhouse publisher with lots to use its clients. After decades of consistent success at the helm of top-tier companies like Tesla and Space, X, Elon Musk is a family name throughout many of America. If you understand even a little bit about the market, you know that he has a reputation as a King Midas of sorts. last week. Everything he touches turns to gold! Jeff is well aware of Elon Musk's executive expertise, so he constantly has an eye out for the Silicon Valley rock star's next move. This time, Jeff has an early lead on Elon's next huge job.
In reality, Brown thinks S.A.V. jeff brown. might be "the biggest trend of the 2020s, and he's not alone. Take a look at these quotes from other widely known S.A.V. bulls: Elon's next big act will be marrying 2 advanced innovations: artificial intelligence and electric automobiles. Musk hopes the combination will assist him establish the very first fully-autonomous, self-driving automobiles ever. It's absolutely nothing short of the vehicle industry's Holy Grail. As you know, electrical cars and self-driving automobile stocks have actually been big this year, however the Wall Street machine has actually approved buzz without much tangible outcome. Despite an extreme boost in competition over the previous couple of years, Brown still believes Musk has the very best opportunity of putting all of it together.
tech could be the magic string that connects it all together. S.A.V. stands for Shared Autonomous Car, and it might be the future of transport. Essentially, this technology would allow you to rent out your vehicle as a self-governing, self-driving taxi when you're not utilizing it. You simply get out of the vehicle and press a button on an app that informs the cars and truck to "join the fleet." Next thing you understand, you're unwinding on your couch while your automobile shuttles ride-sharers around town. Best of all, you get to keep a substantial portion of the revenues. It sounds ridiculous, however it might be closed than you think.